Oct 4 07
Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
Copyright © Aegerion Pharmaceuticals, Inc. All rights reserved.
Aegerion Pharmaceuticals, Inc. CenterPointe IV, 1140 Route 22 East, Suite 304, Bridgewater, NJ 08807 [T: 908-707-2100 F: 908-541-1155]
